The Scientist Expands its Horizons

A new year often brings about change. If you are reading this from the print version, you already see a smaller, more convenient, size. With this first issue in a new design and format, we are happy to welcome 25,000 new subscribers in Europe and Canada. We hope you will find The Scientist as enlightening, valuable, and entertaining as the 50,000 US life scientist subscribers have. The start of a new year also prompts people to reflect on what they can do to improve their lives and the lives of

Written byLarry Hand
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The start of a new year also prompts people to reflect on what they can do to improve their lives and the lives of others. This kind of thinking, however, began much earlier in 2001. The horrible events of Sept. 11 sent us spiraling into deep thought. How could such things happen, and why?

Since then, scientists have been considering more seriously than ever what they do, how they do it, and, particularly, how they communicate with nonscientists. In recent issues of The Scientist, we've reported on this effort in a number of articles, and we continue to do so in this issue. A common theme pervades: Scientists have the ability to change the world.

Our cover story by Ricki Lewis sets the stage. Recent studies of single nucleotide polymorphisms, the single-base sequence variants that make one person different from another, provide further evidence of how little genetic variation exists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies